The aim of the present work was to study the effect of angiotensin II (Ang II) on catecholamines and neuropeptide Y (NPY) release in primary cultures of human adrenal chromaffin cells. Ang II stimulates norepinephrine (NE), epinephrine (EP) and NPY release from perifused chromaffin cells by 3-, 2-and 12-fold, respectively. The NPY release is more sustained than that of catecholamines. We found that the receptor-AT 2 agonist, T 2 -(Ang II 4 -8) 2 has no effect on NE, EP and NPY release from chromaffin cells. We further showed that Ang II increases intracellular Ca 2 + concentration ([Ca 
Introduction
It is well established that angiotensin II (Ang II) is able to stimulate catecholamine release from bovine, rat and porcine adrenal chromaffin cells [1] [2] [3] [4] [5] [6] [7] . However, controversy exists about whether AT 1 or AT 2 receptors are involved in this effect in several species [6 -12] . No study is available to clearly demonstrate, in vitro, the effect of Ang II on human adrenal medulla on catecholamine release since this subject has been debated almost 40 years ago [13] . Neuropeptide Y (NPY) is a 36-amino-acid peptide present in the adrenal medulla of many species, including humans [14 -16] and is co-localized with catecholamines in the same granules [17] . Functionally, NPY potentiates the effect of various agonists such as Ang II and norepinephrine (NE) in addition to exerting a direct contractile effect on the vasculature [18] . We have previously found that NPY, like nicotine, increases catecholamine release from human chromaffin cells through the NPY y3 receptor [19] . The aim of this work was to study the effects of Ang II on NE, epinephrine (EP) and NPY secretions in human adrenal chromaffin cells in culture.
Materials and methods

Peptides and antagonists
Angiotensin II was purchased from Novabiochem (Laufelfingen, Switzerland). T 2 -(Ang II 4 -8) 2 is a templateassembled peptide agonist for AT 2 
Adrenal glands and cell culture
The study was approved by the Hospital Transplantation Review Board and by the Medical Direction. For these studies, adrenal glands were obtained from four kidney transplant donors. All the donors were brain dead patients whose relatives had accepted multiorgan procurement. Chromaffin cells were isolated by the procedure described previously [19] . We shown that such preparation with differential plating allowed to obtain at least 95% pure chromaffin cell in culture.
Assay of [Ca 2+ ] i
Intracellular free calcium concentration ([Ca 2 + ] i ) was determined using the fluorescent probe fluo-3/AM (Molecular Probes) as previously described [22] . Cells were preincubated for 2 min with the AT 1 antagonist Candesartan (1 AM) prior the addition of Ang II.
Release experiments
Cells were plated on glass coverslips placed in a perifusion chamber warmed at 37 jC and stabilized for 90 min at a flow rate of 0.35 ml/min with Krebs buffer (KB). The drugs were administered in KB as a prolonged infusion. Samples were then collected alternately every 2 min for NPY and catecholamine assays [19] . At the end of the perifusion, the coverslips were recovered and the cells lyzed with 0.5 ml of 0.4 M perchloric acid and sonicated. After centrifugation, an aliquot of supernatant was used to measure catecholamines and NPY. Catecholamines (NE and EP) were determined by HPLC with electrochemical detection (Waters, Milford, MA) [23] . NPY concentrations were measured by enzyme immunoassay [24] .
Statistical methods
All values are expressed as mean F S.E.M.. The data were compared by one-way analysis of variance with post hoc analysis using Student's unpaired t-test according to Bonferroni's method.
Results
Angiotensin II stimulates catecholamine and NPY secretions
In perifused chromaffin cells, catecholamines and NPY are constitutively released (Fig. 1A) . NE, EP and NPY are secreted at a rate of 0.08 F 0.01%, 0.07 F 0.007% and 0.07 F 0.008% of intracellular content/2 min, respectively. The AT 2 agonist T 2 -(Ang II 4-8) 2 (500 nM) infusion for 20 min had no effect on catecholamine, and NPY release by chromaffin cells with NE, EP and NPY are secreted at a rate of 0.06 F 0.01%, 0.07 F 0.008% and 0.06 F 0.003% of intracellular content/2 min, respectively. Chromaffin cells constitutively released similar amounts of NE and EP representing 53% of total catecholamine secreted. In contrast, Ang II (100 nM) infusion for 20 min increased the release of both NPY and catecholamines by about 12-and 3-fold, respectively (Fig. 1B and C) . Ang II produced a higher increase of NE secretion compared to the one observed for EP; therefore, AngII caused a preferential release of secretory granules that contain NE over those that are filled with EP or NPY, representing 80% of total catecholamine secreted.
The pattern of secretion is divided into two phases; a few seconds after exposure to Ang II, NE, EP and NPY were secreted apparently simultaneously with a peak at 4 -6 min. However, NE and EP secretion returned to basal levels within 10 min after the addition of Ang II, whereas 10 min after removal of Ang II, NPY secretion rate was still higher than basal release (Fig. 1A) . KCl was the most potent stimulus for catecholamine and NPY secretion (Fig.  1A) . (Table 1 ). In addition, the AT 2 agonist T 2 -(Ang II 4-8) 2 (100 nM) had no effect on [Ca 2 + ] i (Table 1 ).
Signal transduction induced by angiotensin II receptors in chromaffin cells
Discussion
Numerous lines of evidence indicate that Ang II stimulates catecholamine secretion from the adrenal medulla of several species [1 -7] . However, the involvement of AT 1 and AT 2 receptors in such effect is also dependent on the animal species studied [6] [7] [8] [9] [10] [11] [12] . It has been shown that cultured porcine chromaffin cells secreted catecholamines in response to an AT 2 agonist [9] , whereas other studies have shown that Ang II increases catecholamine release from bovine chromaffin cells through functionally active AT 1 receptors [12] . Interestingly, some investigations reported mixed population of Ang II receptors in adrenal medulla depending on the species studied; for instance, AT 2 receptors accounted for 95% of Ang II binding sites in rat adrenal medulla, and 5% of the remaining binding sites were AT 1 [14] . Binding experiments are in agreement with functional studies since the AT 2 receptor agonist CGP42112 induced catecholamine release from the rat adrenal medulla and the effect of Ang II was markedly inhibited by the AT 2 antagonist PD123319, but was not affected by the AT 1 antagonist Losartan [7] . However, a slight inhibitory effect of Losartan on catecholamine release evoked by Ang II indicated that AT 1 receptors could be partially involved [7] . Indeed, another study reported that the catecholamine release from rat adrenal medulla was mainly mediated by AT 1 stimulation linked to an increase in cytosolic calcium concentrations [6] . The exact subtype of Ang II receptor(s) in human adrenal medulla is not clearly established since one study reports that mRNA encoding for the AT 1 receptor predominates (85%) over the AT 2 receptor (15%) [10] , whereas contradictory autoradiographic studies reveal that AT2 receptors are found mainly in the medulla [11] . We have previously shown that AT 1 receptors are transcribed and translated in functional proteins in a human pheochromocytoma and that Ang II increases intracellular calcium and induces a dose-dependent secretion of NE and NPY in pheochromocytes [25] . Our present findings demonstrate that Ang II increases catecholamine secretion on human chromaffin cells through the AT 1 receptor since our AT 2 agonist was ineffective. Therefore, we used a high concentration of T2-(AngII 4-8) 2 (500 nM) far above the IC 50 (190 nM) on AT 2 receptor to ensure that the peptidomimetic occupied 90% of the binding site available in a preparation of cells expressing the AT 2 receptor [26] . Unfortunately, the cellular effects linked to AT 2 stimulation are generally difficult to be demonstrated and despite the lack of positive control for our AT 2 agonist with chromaffin cells, this molecule has proven to be active in various models where the AT 2 receptor was involved [20, 21] . We observed a preferential secretion of NE rather than EP in response to Ang II, suggesting that stimulus-secretion coupling of the exocytic machinery may be different for EP-and NEcontaining cells as previously found in bovine chromaffin cells [27] . The fact that the AT 1 antagonist Candesartan blocked the Ang II-induced [Ca 2 + ] i mobilization establishes that the link between transduction and secretion occurred via the AT 1 receptor. The finding that Ang II evokes a simultaneous release of NPY, EP and NE is in favor of a common storage of NPY within NE and/or EP granules; moreover, the long-lasting secretion of NPY even after the end of Ang II infusion might reflect the existence of a distinct pool of granules containing mainly NPY. We previously observed the same phenomenon when nicotine was used as a secretagogue [19] . Since NPY released from the adrenal medulla could locally enhances the secretion of catecholamine through a autocrine/paracrine mechanism [19] , we postulated that the Ang II-induced NPY secretion also contributes to enhance a sustain secretion of catecholamine.
